Placental genomic risk scores and early neurodevelopmental outcomes
Open Access
- 8 February 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (7)
- https://doi.org/10.1073/pnas.2019789118
Abstract
Tracing the early paths leading to developmental disorders is critical for prevention. In previous work, we detected an interaction between genomic risk scores for schizophrenia (GRSs) and early-life complications (ELCs), so that the liability of the disorder explained by genomic risk was higher in the presence of a history of ELCs, compared with its absence. This interaction was specifically driven by loci harboring genes highly expressed in placentae from normal and complicated pregnancies [G. Ursini et al., Nat. Med. 24, 792–801 (2018)]. Here, we analyze whether fractionated genomic risk scores for schizophrenia and other developmental disorders and traits, based on placental gene-expression loci (PlacGRSs), are linked with early neurodevelopmental outcomes in individuals with a history of ELCs. We found that schizophrenia’s PlacGRSs are negatively associated with neonatal brain volume in singletons and offspring of multiple pregnancies and, in singletons, with cognitive development at 1 y and, less strongly, at 2 y, when cognitive scores become more sensitive to other factors. These negative associations are stronger in males, found only with GRSs fractionated by placental gene expression, and not found in PlacGRSs for other developmental disorders and traits. The relationship of PlacGRSs with brain volume persists as an anlage of placenta biology in adults with schizophrenia, again selectively in males. Higher placental genomic risk for schizophrenia, in the presence of ELCs and particularly in males, alters early brain growth and function, defining a potentially reversible neurodevelopmental path of risk that may be unique to schizophrenia.Funding Information
- HHS | NIH | National Institute of Mental Health (95-M-0150 ZIA MH002942-05)
- HHS | NIH | National Institute of Mental Health (P50MH094268)
- Foundation of Hope for Research & Treatment of Mental Illness (NA)
- Brain & Behavior Research Foundation (NARSAD Young Investigator Grant)
- The John and Polly Sparks Foundation, Bank of America, Trustee (NA)
This publication has 93 references indexed in Scilit:
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Decanalization, brain development and risk of schizophreniaTranslational Psychiatry, 2011
- A transient placental source of serotonin for the fetal forebrainNature, 2011
- Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathwaysPlacenta, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- No Effect of a Common Allelic Variant in the Reelin Gene on Intermediate Phenotype Measures of Brain Structure, Brain Function, and Gene ExpressionBiological Psychiatry, 2010
- Differential Placental Gene Expression in Severe PreeclampsiaPlacenta, 2009
- Altered Global Gene Expression in First Trimester Placentas of Women Destined to Develop PreeclampsiaPlacenta, 2009
- Enuresis as a premorbid developmental marker of schizophreniaBrain, 2008
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesAmerican Journal of Human Genetics, 2007